Quantcast

Latest Everolimus Stories

2015-05-27 08:35:45

-- Overall survival data for Tafinlar® and Mekinist® combination to be presented in metastatic BRAF V600E/K mutation-positive cutaneous melanoma EAST HANOVER, N.J., May 27, 2015 /PRNewswire/

2015-05-19 08:38:20

- More Than 100,000 People with Coronary Artery Disease Have Been Treated with Absorb PARIS, May 19, 2015 /PRNewswire/ -- Abbott announced today that it has received CE Mark for

2015-05-19 08:38:11

PARIS, May 19, 2015 /PRNewswire/ -- At the late-breaking trials session today at EuroPCR, the official congress of European

2015-05-19 08:38:00

Additional Data from EVOLVE II Pivotal Trial Demonstrate Safety and Performance in Patients with Diabetes at One Year MARLBOROUGH, Mass., May 19, 2015 /PRNewswire/ -- Boston Scientific (NYSE:

2015-03-16 12:28:03

Study in New England Journal of Medicine Examines Outcomes of Over 18,000 Patients with Coronary Artery Disease NEW YORK, March 16, 2015 /PRNewswire-USNewswire/ -- Newer drug-coated

2014-12-02 00:21:56

- Update on complete remissions with personalized cell therapy CTL019 in patients with relapsed/refractory acute lymphoblastic leukemia EAST HANOVER, N.J., Dec.

2014-11-19 12:29:10

EVOLVE II Trial Represents the First Successful U.S. Pivotal Trial of a Bioabsorbable Polymer Stent MARLBOROUGH, Mass., Nov. 19, 2014 /PRNewswire/ -- In the first successful U.S.

2014-10-20 08:31:41

First Patient Enrolled in PLATINUM Diversity Trial Evaluating Performance in Women, Black Americans, Latinos/Hispanics, Native Americans and Alaska Natives with Coronary Artery Disease

2014-09-27 08:21:23

- Afinitor led to an unprecedented median overall survival of 44 months, which represents a clinically meaningful while not statistically significant improvement(1) EAST HANOVER,


Word of the Day
meacock
  • An uxorious, effeminate, or spiritless man.
  • A timorous, cowardly fellow.
Probably a blend of meek and cock, or from meek +‎ -ock (“diminutive suffix”).